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Background: Recent studies have demonstrated that low and high birth-weight at birth are risk factors of
developing diabetes. The aim of this study was to determine if the abnormal birth-weight is related with
hyperinsulinemia and elevated index of the Homeostasis Model assessment for Insulin Resistance (HOMA-IR) at
birth, in at term newborns.
Methods: Newborns with gestational age between 38 and 41 weeks, products of normal pregnancies of healthy
mothers aged 18 to 39 years, were eligible to participate. Small-for-gestational age (SGA) and large-for-gestational
age (LGA) newborns were compared with appropriate-for-gestational (AGA) age newborns. Incomplete or unclear
data about mother’s health status, diabetes, gestational diabetes, history of gestational diabetes, hypertension,
pre-eclampsia, eclampsia, and other conditions that affect glucose metabolism were exclusion criteria.
Hyperinsulinemia was defined by serum insulin levels ≥13.0 μU/mL and IR by HOMA-IR ≥2.60. Multiple logistic
regression analysis was used to determine the odds ratio (OR) that computes the association between birth-weight
(independent variable) with hyperinsulinemia and HOMA-IR index (dependent variables).
Results: A total of 107 newborns were enrolled; 13, 22, and 72 with SGA, LGA, and AGA, respectively.
Hyperinsulinemia was identified in 2 (15.4%), 6 (27.3%), and 5 (6.9%) with SGA, LGA, and AGA (p=0.03), whereas IR in
3 (23.1%), 8 (36.4%), and 10 (13.9%) newborns with SGA, LGA and AGA (p=0.06). The LGA showed a strong
association with hyperinsulinemia (OR 5.02; CI 95%, 1.15-22.3; p=0.01) and HOMA-IR (OR 3.54; CI 95%, 1.03-12.16;
p=0.02); although without statistical significance, the SGA showed a tendency of association with hyperinsulinemia
(OR 2.43; CI 95%, 0.43-17.3 p=0.29) and HOMA-IR (OR 1.86; CI 95%, 0.33-9.37; p=0.41).
Conclusions: Our results suggest that LGA is associated with hyperinsulinemia and elevated HOMA-IR at birth
whereas the SGA show a tendency of association.Background
The type 2 diabetes is a complex disease characterized by
decrease of insulin sensitivity and impaired insulin secre-
tion [1]. Recent studies have demonstrated that low birth-
weight is a risk factor for development of obesity and type
2 diabetes in adulthood [2], association that could be
explained because during intrauterine growth the fetus
does not promote the appropriate growth of beta cells
[3,4]. Furthermore, children with history of high birth-
weight also have an elevated risk of developing obesity
and type 2 diabetes later in life [5-7]. The causal relation-
ship between birth-weight and the presence of glucose* Correspondence: guerrero_romero@hotmail.com
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distribution, and reproduction in any mediummetabolic disorders in the adulthood describe a U curve
with the low and high birth-weight showing increased
risk.
In addition to genetic predisposition, nutritional, and
environmental factors, it has been reported that the ele-
vated levels of cytokines increase glucocorticoid activity
and decrease serum adiponectin during pregnancy, which
affects birth-weight [8-11]. Furthermore, insulin, which
is regulated by fetal tissue, is an essential endocrine
regulator of intrauterine growth [12-14].
It has been described that in large-for-gestational age
(LGA) infants, cord serum levels of leptin are strongly
related with birth-weight and insulin levels, suggesting
that part of insulin’s effect on birth-weight is mediated by
leptin [15]. Furthermore, also it has been reported that
conditions that modify insulin concentration during fetald Central Ltd. This is an Open Access article distributed under the terms of the
/creativecommons.org/licenses/by/2.0), which permits unrestricted use,
, provided the original work is properly cited.
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tem, predisposing to insulin resistance in adult life [16,17].
Given that studies about association between birth-
weight and insulin resistance has been developed
measuring insulin and glucose levels in adolescence or
adulthood and collecting information of birth-weight in
a retrospective way, the aim of this study was to deter-
mine if the abnormal birth-weight is related with ele-
vated insulin levels and increase of the Homeostasis
Model assessment for Insulin Resistance (HOMA-IR)
index at birth, in at term newborns.Methods
With protocol approval by the Mexican Social Security
Institute Research Committee and after obtain the
mother’s informed consent, a cross-sectional study of
two phases was carried out.
In the first phase, with the purpose of establish the
cutoff point of HOMA-IR at birth in appropriate-for-
gestational age (AGA) newborns delivered at term, a
total of 150 newborns with birth-weight greater than
2500 g and lower that 4000 g, were enrolled in a cross-
sectional non-comparative study.
In the second phase, an independent sample of 107
newborns were enrolled in a cross-sectional comparative
study to determine if LGA or small-for-gestational age
(SGA) is related with hyperinsulinemia and elevated
HOMA-IR in newborns delivered at term.
In both phases, eligible participants were newborns of
mother’s aged 18 to 39 years and gestational age (deter-
mined by ultrasound) between 38 and 41 weeks. All
newborns were of pregnant women without diagnosis of
diabetes or gestational diabetes (confirmed by oral glu-
cose tolerance test), history of gestational diabetes, high
blood pressure, pre-eclampsia, eclampsia, asthma, epi-
lepsy, or malnutrition.
In addition, in both phases the presence of conge-
nital malformations, incomplete or unclear data about
mother’s health status as well as preterm delivery, intra-
uterine infection, smoking or alcohol consumption dur-
ing pregnancy, and the use of dextrose solutions during
labor, or drugs that affect the glucose metabolism, were
exclusion criteria.
In the second phase of the study, in order to control
potential confounders related with maternal characteris-
tics, the groups were matched by mother’s age, parity,
and gestational age.
Anthropometric characteristics and blood samples
were obtained by pediatricians at delivery room, imme-
diately after delivery. Blood samples were collected from
the umbilical cord vein.
Newborns were distributed in the groups in study
according the presence of SGA, AGA, or LGA.Detailed information regards mother’s health was col-
lected by direct medical history, physical examination, and
by reviewing their medical records of prenatal control.
The body mass index (BMI) of mothers before preg-
nancy was calculated as the weight (kilograms) divided
by the height (meters) squared. The height and weight
were assessed with a stadiometer using a fixed scale. The
increments of the weight and height measurements were
0.1 kg and 0.01 m, respectively.
Definitions
SGA, AGA, and LGA were defined by weight at birth
<2500g, ≥2500<4000g, and >4,000g, respectively [18,19].
The HOMA-IR index was calculated using the for-
mula: fasting insulin (μU/mL) x fasting glucose (mmol/
L)/22.5 [20].
Assays
Serum glucose was measured using the glucose-oxidase
method (Sigma Diagnostics, St Louis, Mo, USA). The
intra- and inter-assay coefficients of variation for glucose
measurements were 2.1 and 2.8%. Insulin levels were
measured by microparticle enzyme immunoassay (Abbott
Axsym System, Alameda, CA, USA), with intra- and
inter-assay variation coefficients of 4.1% and 6.2%.
Statistical analysis
Differences between the groups were estimated using
one-way ANOVA with post hoc Bonferroni test. The
Logn was calculated to normalize skewed data.
Multiple regression logistic analysis adjusted by mater-
nal weight before pregnancy and sex of newborn was
used to determine the odds ratio (OR) that computes
the association between birth-weight (independent vari-
able) with hyperinsulinemia and HOMA-IR index (de-
pendent variables).
The 95% confidence intervals (CI 95%) were deter-
mined, and a P value <0.05 defined statistical signifi-
cance. Data were analyzed using the statistical package
SPSS 15.0 (SPSS Inc., Chicago IL, USA).
Results
The characteristics of the mothers and newborns enrolled
in the first phase of the study are shown in Table 1.
Distributions of insulin, glucose, and HOMA-IR at
birth of AGA newborns are shown in Table 2; the 90th
percentile of distribution for insulin levels was 13.0 μU/mL
and the fourth quartile of HOMA-IR index 2.60. In the
absence of cutoff points for insulin levels and HOMA-IR
index in the newborn at term, these values were consid-
ered as the cutoff points for the second phase of the
study.
In the second phase of the study, 13 (12.1%), 22
(20.6%), and 72 (67.3%) newborns delivered at term
Table 1 Characteristics of pregnant women and
birth-weight of newborns appropriate-for-gestational
age delivered at term, N=150
Family history of diabetes, n (%) 58 (38.6)
Parity 2.4 ± 3.2
Mother’s age, years 25.2 ± 5.2
Weight before pregnancy, kg 60.2 ± 11.8
Body mass index before pregnancy, k/m2 23.8 ± 4.3
Weight gain through pregnancy, kg 12.6 ± 4.0
Gestational age, weeks 39.2 ± 1.2
Newborn’s birth weight, g 3278 ± 321
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respectively.
Clinical and biochemical characteristics of the mothers
and newborns in the second phase of the study are
shown in Table 3.
The mother’s weight and BMI before pregnancy was
significantly lower in the mothers of SGA newborns as
compared with mother’s of LGA and AGA newborns.
The insulin levels in the newborns were significantly
higher in the LGA group as compared with the SGA
and AGA groups. Other variables showed no significant
differences between the groups in study.
Hyperinsulinemia was identified in 13 (12.1%) new-
borns: 2 (15.4%), 5 (6.9%), and 6 (27.3%) in the groups
with SGA, AGA, and LGA (p=0.03).
Elevated HOMA-IR was detected in 21 (19.6%) new-
borns: 3 (23.1%), 10 (13.9%), and 8 (36.4%) in the groups
SGA, AGA, and LGA (p=0.063).
The LGA show a strong association with hyperinsuli-
nemia (OR 5.02; CI 95%, 1.15-22.3; p=0.01) and HOMA-Table 2 Characteristics of the target population according to
Overall population
n= 107
Family history of diabetes, n (%) 45 (40.1)
Parity 2.2 ± 1.0
Mother’s age, years 25.0 ± 5.0 2
Weight before pregnancy, kg 61.8 ± 11.7 5
Weight gain through pregnancy, kg 13.0 ± 5.2 1
Body mass index before pregnancy, k/m2 24.1 ± 4.6 2
Gestational age, weeks 39.1 ± 1.8 3
Newborn’s birth weight, g 3312 ± 678 20
Newborn’s plasma glucose at birth, mmol/L 5.9 ± 2.7
Newborn’s insulin at birth, μU/mL 7.1 ± 4.3
HOMA-IR index 1.9 ± 1.5
Values are median ± standard deviation.
SGA, small-gor-gestational age; AGA, appropriate-for-gestational age; LGA, large-for
*p< 0.01 between SGA and LGA. **p< 0.005 between SGA and the overall populat
{p< 0.05 between LGA and AGA. }p= 0.04 between SGA and AGA.IR (OR 3.54; CI 95%, 1.03-12.16; p=0.02); the SGA
showed a tendency of association with hyperinsulinemia
(OR 2.43; CI 95%, 0.43-17.3 p=0.29) and HOMA-IR (OR
1.86; CI 95%, 0.33-9.37; p=0.41).
Discussion
Results of this study suggest that at LGA newborns have
higher insulin levels and HOMA-IR than AGA and SGA
newborns.
It has been suggested that the association between
LGA and insulin resistance may reflect the influence of
several factors like maternal diabetes and gestational
age [21-24]; in the second phase of the study, to con-
trol these potential confounders, the mother’s age, par-
ity, and gestational age of mothers in the groups of
newborns with SGA, AGA, and LGA, were matching
criteria.
Our results agree with the report by Wolf et al. [15]
who found in the cord blood of 175 neonates with a
birth-weight of 3376±588g, insulin levels of 7.4±4.3 μU/mL
as compared with our results in 107 at term newborns
with birth-weight and insulin levels of 3313±678g and
7.1±4.3 μU/mL. However, the increase of insulin levels,
according birth-weight class, in the study by Wolf et al.
(SGA<AGA<LGA) showed a different sequence as com-
pared with our results (AGA<SGA<LGA); finding that
could be related with differences in the birth-weight
of the LGA newborns, which were heavier (3824±364g ver-
sus 4175±197g), and/or the birth-weight of SGA new-
borns (2516±352g versus 2083±356g) that were lighter
in our study as compared with the report by Wolf et al.
[15]. Finally, in addition to leptin, also differences in glu-
cose levels could explain differences in the sequence ofbirth weight, n = 107
SGA AGA LGA
n=13 n=72 n=22 F p
8 (61.5) 26 (36.1) 11 (50.0) - 0.13
2.3 ± 1.2 2.0 ± 1.0 2.4 ± 1.0 0.94 0.39
3.0 ± 6.1 24.8 ± 5.2 26.6 ± 3.9 2.14 0.12
5.9 ± 11.8 61.1 ± 10.6 67.5 ± 13.2 4.60 0.01*, **,†
1.1 ± 6.7 12.8 ± 5.3 14.7 ± 3.2 1.95 0.14
2.1 ± 5.1 23.9 ± 4.0 25.8 ± 5.5 2.8 0.06
9.0 ± 0.8 39.3 ± 1.2 39.8 ± 0.9 2.22 0.11
83 ± 356 3270± 380 4175± 197 149.3 <0.001*,**,†,{,}
7.2 ± 5.5 5.8 ± 2.0 5.2 ± 2.2 2.15 0.15
6.7 ± 4.5 6.3 ± 3.7 9.6 ± 4.9 5.32 0.001{
1.9 ± 1.4 1.7 ± 1.3 2.3 ± 1.5 1.63 0.04{
-gestational age.
ion. †p< 0.005 between LGA and the overall population.
Table 3 Distribution of cord serum levels of insulin, glucose and HOMA-IR index in newborns appropriate-for-
gestational age delivered at term, N=150
Percentiles
Mean± SD 5 25 50 75 90
Newborn’s insulin at birth, μU/mL 8.2 ± 8.8 2.42 3.90 5.60 8.80 13.0
Newborn’s plasma glucose at birth, mmol/L 6.1 ± 1.9 3.9 4.7 5.6 6.2 6.7
HOMA-IR 2.2 ± 2.5 0.52 0.94 1.51 2.60 2.89
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leptin and Wolf et al. [15] did not report glucose levels,
the results are not comparable in this issue. However,
because criteria to define SGA and LGA at birth were
not the same, the comparison between our results and
those from Wolf et al. should be taken cautiously.
Furthermore, in our study the sequence by weight
class in the newborn at birth, for glucose and HOMA-IR
was LGA<AGA<SGA and AGA<LGA<SGA, respectively,
suggesting that LGA newborns at birth exhibited a decrease
of insulin sensitivity, that requires an elevated compensa-
tory insulin secretion from fetus to maintain euglycemia.
Recently, Catalano et al. [25] conducted a comparative
study that included 53 lean and 68 obese pregnant
women to verify if fetuses of obese women have in-
creased insulin resistance. Although we did not analyze
our data based on the BMI of pregnant women, our
results agree with the report by Catalano et al. On this
regard, the birth-weight of newborns of lean and obese
women (3217±452g and 3320±460g) in the study by
Catalano et al. [25] is similar to the birth-weight of AGA
newborns in our study (3270±380g), as was the HOMA-
IR (1.51±0.86 vs. 1.06±0.70 in the newborns of obese
and lean mothers, in the study by Catalano) and 1.7±1.3
in the AGA newborns of our study. Furthermore, Catalano
et. al. [25] also reported that there was a positive correl-
ation between fetal insulin resistance and fetal adiposity
supporting our finding that suggest that elevated body-
weight at birth might be the main risk factor involved
in the development of hyperinsulinemia and elevated
HOMA-IR in the newborns.
Interestingly, although SGA and AGA newborns
exhibited similar HOMA-IR, blood cord glucose levels
were higher in the SGA newborns, suggesting that could
be an impaired insulin secretion and or insulin action
related with the low birth-weight at birth. Additional
factors related with the insulin production by fetus, such
as elevated leptin and decreased adiponectin levels also
could explain the findings of our study in regards SGA
newborns. Further studies with the appropriate bio-
chemical measurements are needed.
Recently, in the Hyperglycemia and Adverse Preg-
nancy Outcome Study, it has been reported that cord
serum C-peptide levels are strongly related with percent
body fat of newborns and mothers glycemia [26];although we have not data about mothers glycemia, our
results based in measurement of cord insulin levels im-
mediately after delivery, are in agree with these finding
and support the statement of a strong relationship be-
tween increase of insulin by fetus and the increase of
body weight at birth.
In regards the association between birth-weight and
insulin resistance later in life, children and young adults
with history of very low birth-weight and preterm deliv-
ery exhibit higher indices of HOMA-IR as compared
with newborns delivered at term [27-29]; given that SGA
newborns have accelerated weight and fat mass gain dur-
ing first years of life is expected the development of in-
sulin resistance later in life in these children [30]. Taking
into account that SGA newborns in our study exhibited
low HOMA-IR, is probable that the increase of leptin
levels related with the increase of fat tissue have an im-
portant role in the transition from low insulin secretion
and HOMA-IR at birth to high insulin secretion and
HOMA-IR at childhood. Further research is needed in
the field to clarify underwent mechanisms involved in
the fetal insulin secretion.
An additional contribution of our study was the refer-
ence values of cord insulin levels and HOMA-IR in
AGA newborns. On this regard, because there are not
reference values of insulin and HOMA-IR at birth, we
evaluate its distribution in an independent group of
AGA newborns who had the same inclusion and exclu-
sion criteria that newborns enrolled in the second phase
of this study. In this way, we obtained the percentile dis-
tribution of insulin levels and HOMA-IR as reference
value of both variables.
Finally, it is necessary to keep in mind that mechanisms
involved in the relationship between fetal growth and insu-
lin resistance have not been established with certainty;
therefore, further studies in the field are necessaries.
Several limitations deserve to be mentioned. First, the
small sample size of LGA or SGA newborns in this study
could be a source of bias that affects our conclusion.
However, given the inclusion and exclusion criteria of
this study, is unlikely to find newborns at term with
LGA or SGA; further research that includes multiple
centers is necessary to increase the sample size in order
to confirm our results. Second, the cause-effect relation-
ship cannot be established with certainty in the cross-
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designs could involve ethical issues.
The homogeneous target population and the strict
matching criteria for controlling the main confounders
were the main strengths of this study. In addition, given
that pregnant women were in prenatal control, we have
reliable data about maternal characteristics.
Conclusion
In conclusion, our results suggest that LGA is associated
with hyperinsulinemia and elevated HOMA-IR at birth
whereas SGA show a tendency of association.
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